Summary. Ovaries from 8-week-old female NMRI mice in different stages of the oestrous cycle, or from females neonatally treated with the synthetic oestrogen diethylstilboestrol (DES; 5\p=n-\10\m=-\6 \g=m\gdaily for 5 days), were studied histologically and for the ability to synthesize steroids from [3H]pregnenolone in vitro. Daily doses of 10\ m=-\ 4 \ g=m\ g DES or higher resulted in absence of corpora lutea. In ovaries lacking corpora lutea, the interstitial tissue dominated and the cells in this compartment were large with a clear cytoplasm.
Introduction
In 1962, Takasugi, Bern & DeOme described a persistent vaginal cornification in adult mice treated with oestrogen in the neonatal period. Later, a dose-dependent vaginal response was reported ; high doses of oestradiol resulted in ovary-independent vaginal cornification while lower doses (5 µg daily) resulted in ovary-dependent cornification (Kimura, Basu & Nandi, 1967) . The ovary-independent type was related to direct effects of oestrogen in the target organ (Takasugi, Kimura & Mori, 1970) while the ovary-dependent type was ascribed to a changed ovarian function, in turn a result of failure of the normal cyclic LH peak (Gorski, Harlan & Christensen, 1977) . Beside permanent vaginal cornification, neonatal oestrogen treatment results in the occurrence in the upper part of the vagina and in the uterine cervix of a heterotopic columnar epithelium which after puberty develops into adenosis and later into morphological malignancy (Forsberg & Kalland, 1981) . This progression has been shown to be ovary-dependent. Natural (oestradiol-17ß) and synthetic (diethylstilboestrol, DES) oestrogens both induce persistent vaginal cornification and adenosis but a further progression has only been observed after DES treatment (Forsberg & Kalland, 1981) .
When mice are treated neonatally with oestrogens, their ovaries as adults are characterized by absence of corpora lutea, presence of follicles in various stages of development, and hyperplasia and hypertrophy of the interstitial tissue (Takasugi & Bern, 1964; Kimura et ai, 1967; Forsberg, 1969; Mori, 1979 (Falck, 1959) . Because corpora lutea are lacking in neonatally oestrogen-treated mice, the pattern of ovarian steroid synthesis might be abnormal. Oestrogens inhibit the A5-3ß-hydroxysteroid dehydrogenase-A5-A4-isomerase complex which is responsible for conversion of 5 to 4 steroids (Goldman & Bongiovanni, 1967 ;  Goldman, 1974;  Spona, 1982 Spona, , 1983 .
The aim of the present study was to investigate steroid synthesis by the ovaries of female mice treated neonatally with DES. In most earlier experiments high doses of DES have been used in the neonatal period (5 µg/day). Dose-response studies on the effects on ovarian morphology and ovarian steroid synthesis were therefore undertaken.
Materials and Methods
Animals. Mice belonging to an NMRI stock were used in most experiments. Inbred NMRI mice (breeding couples were a kind gift from Professor von Deimling, Pathologisches Institut, Freiburg, West Germany) from a stock kept by strict brother-to-sister mating were used for grafting experiments. All animals were fed a standard pellet diet and given water ad libitum. They were kept at constant temperature and humidity and in a 12-h light-12-h dark cycle. When pregnant, the females were put in separate cages to give birth. Within 24 h after birth, females from different litters were pooled and every foster mother was allowed to feed 6-9 female young. The young were weaned at the age of 1 month. Ci/mmol), [l,2,6,7-3H(N) ]progesterone (sp.act. 115 Ci/mmol), [l,2-3H(N) ]20a-hydroxypregn-4-ene-3-one (20a-dihydroprogesterone; sp.act. Ci/mmol) and [l,2,6,7-3H(N) The following non-radioactive steroids were used (all from Sigma Chemicals): A5-pregnen-3ß-ol-20-one (pregnenolone), A4-pregnen-3,20-dione (progesterone), A4-pregnen-17oc-ol-3,20-dione (17a-hydroxyprogesterone), 20a-hydroxy-A4-pregnen-3-one (20a-dihydroprogesterone), 4-androstene-3,17-dione (androstenedione), A5-pregnen-3ß,17a-dihydroxy-20-one ( 17a-hydroxypregnenolone), A5-androsten-3ß-ol-17-one (dehydroepiandrosterone), A4-androsten-7ß-ol-3-one (testosterone), 5a-androstan-3cx-ol-17-one (androsterone), l,3,5(10)-oestratrien-3,17ß-diol (oestradiol-17ß), l,3,5(10)-oestratrien-3-ol-17-one (oestrone) and l,3,5(10)-oestratrien-3,16a,17ß-triol (oestriol). They were all dissolved in ethanol at a concentration of 5 mg/ml. 200 µ NADP (50 µ ) and 100 µ glucose 6-phosphate dehydrogenase (5 units). All the cofactors were dissolved in buffered saline (3 mM-NaH2P04, 6 mM-Na2HP04, 150 mMNaCl; pH 7).
Incubation took place at 37°C in an atmosphere of 95% air and 5% C02 and was interrupted by addition of 3 ml ethyl acetate. After shaking at room temperature during the night, the tubes were centrifuged at 2000 #av for 10 min and the ethyl acetate fraction transferred to new test tubes. The water phase was re-shaken twice, each time with 3 ml ethyl acetate, and centrifuged as above. The result was a pool of 9 ml ethyl acetate with extracted steroids. This pool contained more than 94% of the radioactivity initially added to the homogenate. The ethyl acetate was evaporated and the steroids redissolved in 100 µ ethanol.
Thin-layer chromatography (t.l.c). Silica gel plates 60 F254, pre-coated, 20 20 cm, thickness 0-25 mm (E. Merck, Darmstadt, West Germany) were used. Unlabelled reference steroids and the 100 µ ethanol solution of extracted steroids from the ovarian homogenate were added to the plates and run in a two-dimensional t.l.c. system as described by Bicknell & Gower (1971) . The plates were run twice in a benzene-ether system (9:1 v/v); after turning through 90°, the eluant was benzene-methanol (9 :1 v/v). The carrier steroids were located with u.v. light and 4% sulphuric acid in ethanol. Areas containing visible steroids were scraped off and transferred to scintillation vials. After adding 3 ml scintillation fluid (4 g PPO, 0-3 g POPOP in 1000 ml toluene; PPO Fig. 3 ). The cells were arranged in nodular or cord-like formations. In 8 females treated with 10~5 µg DES for 5 days after birth, the follicles, corpora lutea and interstitial tissue appeared similar to those in controls. None of the ovaries from 8 females treated with a daily dose of 10~4 µg or higher doses (10~3 µg, 9 females; 10"2 µg, 7 females; 10"1 µg, 9 females; 1 µg, 8 females; 5 µg, 8 females) contained any corpora lutea (PI. 1, Fig. 2) . The crosssections from these ovaries were dominated by interstitial tissue and follicles. The interstitial tissue cells were arranged in nodular or cord-like formations, as described for controls, but the cytoplasmic-nuclear ratio was higher and the cytoplasm was clear (PI. 1, Fig. 4 (Text-fig. 2a ). An exception was testosterone for which the graph tended to be curvilinear (Text-fig. 3 ). DES-exposed ovaries had a high initial progesterone production. The radioactivity in the 17a-hydroxyprogesterone area was low for DES-homogenates; it was considerably higher for controls but, after 30 min incubation, it decreased with time. The graphs for androstenedione and testosterone also showed differences between homogenates of control and DES-treated ovaries.
With increasing dilution of the homogenates, the radioactivity in the different plate areas (except that representing 17a-hydroxyprogesterone) decreased (Text-fig. 4 ). The general shape of the androstenedione, progesterone and testosterone graphs was similar for control and DEShomogenates but the level of the lines varied. The graph representing 17a-hydroxyprogesterone in control homogenates had an initial steep increase and later decreased ; it was quite different from that representing 17a-hydroxyprogesterone in DES-homogenates.
Taken together, the results described above indicate that there are differences as regards kinetic behaviour of radioactivity, tentatively taken to represent the steroids mentioned, between control and DES-treated ovaries. Based on these results, the optimal incubation conditions were defined for all the following experiments (see 'Methods').
General comments on the t.l.c. results under optimal incubation conditions. A maximum of 70% of the radioactivity initially added to the starting point on the t.l.c. plates could be accounted for by the total radioactivity in the 10 reference areas on the plates. The different steroids could be divided into a high activity group and a low activity group. Included in the latter were 17a-hydroxypregnenolone, dehydroepiandrosterone, oestrone, oestradiol and oestriol with 2-8% of the total radioactivity added represented in each area, respectively. Only insignificant amounts (about 1%) of androsterone were found. The low-activity group will be the subject for further studies and is not included in the following presentation. The main interest was devoted to the four steroids (progesterone, 17a-hydroxyprogesterone, androstenedione and testosterone) in the high-activity group. The results indicate that the A4 synthetic pathway from pregnenolone was the preferred one and this was the same for control and DES-exposed ovaries. A maximum of 18% of the total radio¬ activity added to the homogenate was recovered from the area representing pregnenolone ; in the majority of incubations the percentage was less than 5%.
Recrystallization experiments. The homogeneity of the 3H-steroids in the different t.l.c. areas tentatively taken to represent progesterone, 17a-hydroxyprogesterone, androstenedione and testosterone was studied in recrystallization experiments. These were run on material from females in different phases of the oestrous cycle as well as on material from DES-exposed ovaries. The results are presented in Table 1 . More than 91% of the radioactivity in the progesterone and androstenedione areas represented these 3H-steroids and this was true for all materials. In contrast to this, the radioactivity within the testosterone and, above all, the 17a-hydroxyprogesterone areas was a more heterogeneous mixture of 3H-steroids. Within the 17a-hydroxyprogesterone area, the heterogeneity was related to the cycle phase and was less in material from pro-oestrous animals than in that from dioestrous, oestrous or DES-treated mice.
In separate experiments we demonstrated that 17a-hydroxyprogesterone and 20a-dihydroprogesterone co-migrated in our two-dimensional t.l.c. system and the suspicion arose that 20a-dihydroprogesterone was responsible for the heterogeneity within the 17a-hydroxyprogesterone area. Because of the position on the plates (Text- fig. 1 ), the same steroids could also be possible candidates for contamination within the testosterone area. After extraction of the steroids within the 17a-hydroxyprogesterone and testosterone areas and re-chromatography in benzene-methanol on a second plate, a further separation was obtained. The results are shown in Table 2 . The material from the 17a-hydroxyprogesterone area on the first t.l.c. plate contained about the same 3H-Steroids were extracted from the area on the t.l.c. plate indicated by the unlabelled reference steroid. After addition of unlabelled reference steroid and 14C-steroid, crystallization was started. 3H : 14C quotients are given both for the original eluate and for the different mother liquors (ML) during various recrystallization steps. The quotient in the final crystals were related to the quotient in the t.l.c. eluate and the results are expressed in percentages. Material from the 17a-hydroxysteroid and testosterone areas on the first two-dimensional t.l.c. plate was extracted with ethyl acetate and further separated on a second plate in a benzene-methanol system.
proportions of 17a-hydroxyprogesterone, 20a-dihydroprogesterone, and testosterone in all the materials studied (41-44%, 53-56%, 1%, respectively). Contrary to this, material from pro-oestrous females had a greater amount of 17a-hydroxyprogesterone (86%) and a lesser amount of 20a-dihydroprogesterone (12%) while the testosterone contamination was insignificant (1%). Material from the first testosterone t.l.c. area was contaminated with 17a-hydroxyprogesterone (Table 2) (Text-fig. 5b ). (5 µ DES)
When ovaries from females treated with daily doses of 5 µg DES in the neonatal period were transplanted to ovariectomized females, the pattern of 3H-steroids formed changed from that characteristic for DES-exposed ovaries to that seen in controls (Text- fig. 6 ). When ovaries from control females were grafted to ovariectomized but neonatally DES-treated females, the steroid pattern was of the same type as that in ovaries from DES-treated females.
From the results presented in , and from the known specific activity of [3H]pregnenolone, the amounts of radioactive steroids formed in the homogenate of one ovary during incubation for 1 h were calculated (Table 3) .
Discussion
Daily doses of 10~4 µg DES, or higher, for the first 5 days after birth resulted in absence of corpora lutea in all ovaries studied from 8-week-old females. The interstitial cells in the same ovaries were large with a clear cytoplasm. This morphology is similar to that earlier described after treating neonatal female mice with high doses (e.g. 5 µg) of oestradiol (Takasugi & Bern, 1964; Kimura et ai, 1967; Forsberg, 1969) . Treatment of pregnant mice with 0-01-100 µg DES per kg bodyweight from Days 9 to 16 of gestation did not result in any consistent effects on corpora lutea in ovaries from the adult offspring, but some females exposed to the 10 and 100 µg doses failed to exhibit these structures (McLachlan, Newbold, Shah, Hogan & Dixon, 1982) . The absence of corpora lutea, at least after neonatal oestrogen treatment, is considered secondary to a distrubance in the hypothalamic-pituitary regulation, resulting in no preovulatory LH peak (Gorski et ai, 1977) .
Pronounced differences were found in pattern of radioactive steroids synthesized from [3H]pregnenolone in ovarian homogenates from females in different phases of the oestrous cycle compared with homogenates of ovaries of mice exposed neonatally to DES (10~4 µg per day or higher doses) and lacking corpora lutea. Progesterone was the main steroid synthesized in DESexposed ovaries, while 17a-hydroxyprogesterone and 20a-dihydroprogesterone were the most prominent ones in control homogenates, their relative amount depending on the phase of the cycle. More [3H]androstenedione was formed in DES-exposed homogenates than in control homogenates while the opposite was true for [3H]testosterone. These differences cannot be explained by the reduced ovarian weight in DES-treated females. The conclusion is that neonatal DES treatment has no permanent inhibitory effect on the A5-3ß-hydroxysteroid dehydrogenase-A5-A4-isomerase complex to judge from the intense progesterone synthesis in the non-cyclic DES-exposed ovaries.
When ovaries from adult, but prenatally DES-exposed, CD-I mice were incubated in vitro for 24 h, an increased content (RIA assay) of progesterone, testosterone and oestrogen was found in the medium on a tissue-weight basis but only testosterone remained elevated on a per-ovary basis (Haney, Newbold & McLachlan, 1984) . These results are thus in contrast to those in the present study in which synthesis of tritiated progesterone, 17a-hydroxyprogesterone, 20a-dihydroprogesterone, androstenedione, and testosterone, differed between DES and control ovaries both on a weight and per-ovary basis. The testosterone level was very low in the DES-exposed ovaries in our study. The RIA assay used by Haney et ai (1984) does not necessarily reflect a true steroidogenic capacity but rather a combination of formation and release of preformed steroids. The pattern of steroidogenesis could also be influenced by the long incubation period as suggested from our kinetic studies.
The DES-induced ovarian effects were reversible, as shown by the grafting experiments, and thus secondary to control mechanisms outside the ovary. The results indicate that the enzyme ac¬ tivity most affected was that of 17a-hydroxylase and 17ß-ol-dehydrogenase. Provided the pituitary gland of adult but neonatally DES-treated mouse females secretes significant amounts of FSH and LH, as it does in neonatally oestrogen-treated rats (Kawashima & Mori, 1971 ; Nagasawa, Yanai, Kikuyama & Mori, 1973 ; Goomer, Saxena & Sheth, 1977) , the enzyme defects could be considered to be a result of a low but continuous LH secretion. However, direct ovarian effects, perhaps not apparent until later in life, should not be excluded (Mori, 1979) . Oestrogens were synthesized from [3H]pregnenolone but the conversion was small and must be further analysed. In spite of the pronounced progesterone synthesis in ovaries from DES-treated females, the vaginal epithelium in the same animals was of a high cornified squamous type and its morphology was ovary-depen¬ dent. This raises further questions about the circulating levels of progesterone and oestrogens and possible non-ovarian metabolic conversions. This investigation was supported by grants from The Swedish Cancer Society, project no. 1870-B83-01XA
